Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1085 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Lannet generic obesity drug

Lannett’s Phentermine HCl Capsules, 37.5mg is the generic version of Teva Pharmaceuticals USA’s Adipex-P Capsules, 37.5mg. Phentermine Hydrochloride (HCl) is used for the short-term management of obesity. Lannett

Swiss researchers deploy Roche Cellavista system

The system is used in the development of an automated liquid-handling cell culture platform for isolating, expanding and characterizing human primary cells. Roche’s Cellavista Imaging noninvasively measures cell

Novartis Q2 net sales up 27%

For the second quarter of 2011, the company has generated net income of $2.73bn, compared to $2.44bn for the same period in the prior year. Net sales were

Millennium submits MM drug sNDA to FDA

VELCADE is indicated for multiple myeloma (MM) and mantle cell lymphoma. The submission contains clinical data from the Phase III VISTA trial comparing the use of VELCADE based

ICON Q2 revenue rises

For the second quarter of 2011, the company has generated net income of $13.08m, compared to $22.87m for the same period in 2010. ICON’s income from operations was

Sun Pharma generic BPH drug gets FDA approval

Sun Pharma’s alfuzosin hydrochloride extended release tablets are the generic version of Sanofi-aventis’ Uroxatral extended release tablets. Uroxatral is approved to treat signs and symptoms of benign prostatic